CD209 and rheumatoid arthritis: Given the potential role of CD209 promoter variants in immune regulation, this case-control study examined the association between CD209 polymorphisms, rs4804803 (-336G > A) and rs735239 (-871G > A), and RA susceptibility in an Egyptian population, while also assessing their association with clinical disease characteristics.